67,599 Shares in Synopsys, Inc. $SNPS Purchased by Osterweis Capital Management Inc.

Key Points

• Osterweis Capital Management purchased 67,599 Synopsys shares valued at approximately $30.2 million, making SNPS its 28th-largest holding; institutional investors collectively own 85.47% of the company.
• Synopsys reported quarterly revenue of $2.28 billion and adjusted earnings of $3.35 per share, exceeding analyst estimates, while revenue increased 41.9% year over year. The company issued fiscal 2026 EPS guidance of $14.72–$14.80.
• SNPS opened at $394.51, well below its 52-week high of $615.79, but analysts maintain a “Moderate Buy” consensus with an average price target of $563.59. CEO and CFO share sales were conducted under pre-arranged plans primarily to cover tax obligations.

Osterweis Capital Management Inc. acquired a new position in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) in the 2nd quarter, according to its most recent filing with the SEC. The fund acquired 67,599 shares of the semiconductor company's stock, valued at approximately $30,154,000. Synopsys makes up 1.4% of Osterweis Capital Management Inc.'s holdings, making the stock its 28th largest position.

A number of other hedge funds have also made changes to their positions in SNPS. Foronjy Financial LLC lifted its position in shares of Synopsys by 5.2% in the fourth quarter. Foronjy Financial LLC now owns 446 shares of the semiconductor company's stock valued at $210,000 after acquiring an additional 22 shares in the last quarter. AGH Wealth Advisors LLC increased its position in shares of Synopsys by 4.4% during the first quarter. AGH Wealth Advisors LLC now owns 569 shares of the semiconductor company's stock worth $226,000 after purchasing an additional 24 shares in the last quarter. Hardy Reed LLC raised its stake in Synopsys by 0.8% in the 4th quarter. Hardy Reed LLC now owns 3,309 shares of the semiconductor company's stock valued at $1,554,000 after purchasing an additional 25 shares during the last quarter. Annis Gardner Whiting Capital Advisors LLC raised its stake in Synopsys by 16.9% in the 4th quarter. Annis Gardner Whiting Capital Advisors LLC now owns 180 shares of the semiconductor company's stock valued at $85,000 after purchasing an additional 26 shares during the last quarter. Finally, MCF Advisors LLC lifted its holdings in Synopsys by 17.8% in the 4th quarter. MCF Advisors LLC now owns 172 shares of the semiconductor company's stock valued at $81,000 after purchasing an additional 26 shares in the last quarter. Institutional investors and hedge funds own 85.47% of the company's stock.

Synopsys Stock Down 0.8%

NASDAQ SNPS opened at $394.51 on Tuesday. Synopsys, Inc. has a 52 week low of $366.00 and a 52 week high of $615.79. The company has a quick ratio of 1.32, a current ratio of 1.43 and a debt-to-equity ratio of 0.33. The business's fifty day simple moving average is $418.53 and its 200-day simple moving average is $439.92. The firm has a market cap of $75.54 billion, a PE ratio of 91.32, a P/E/G ratio of 2.34 and a beta of 1.23.

Synopsys (NASDAQ:SNPS - Get Free Report) last announced its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share for the quarter, beating the consensus estimate of $3.15 by $0.20. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. The firm had revenue of $2.28 billion for the quarter, compared to analysts' expectations of $2.25 billion. During the same quarter in the previous year, the company posted $3.67 EPS. The company's revenue was up 41.9% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. As a group, equities analysts anticipate that Synopsys, Inc. will post 10.64 earnings per share for the current year.

Wall Street Analyst Weigh In

Several brokerages have issued reports on SNPS. Rosenblatt Securities lifted their target price on shares of Synopsys from $530.00 to $575.00 and gave the stock a "buy" rating in a research note on Tuesday, May 26th. Wells Fargo & Company reduced their target price on shares of Synopsys from $535.00 to $450.00 and set an "equal weight" rating for the company in a research report on Tuesday, August 11th. Benchmark reissued a "buy" rating on shares of Synopsys in a research note on Wednesday, August 19th. Robert W. Baird set a $558.00 price target on shares of Synopsys in a research report on Thursday, May 28th. Finally, Citigroup upped their price objective on shares of Synopsys from $600.00 to $610.00 and gave the company a "buy" rating in a research note on Thursday, May 28th. One research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $563.59.

Insider Activity

In other news, CEO Sassine Ghazi sold 14,603 shares of the firm's stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the completion of the sale, the chief executive officer owned 75,020 shares in the company, valued at $34,431,179.20. This trade represents a 16.29% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of Synopsys stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the sale, the chief financial officer directly owned 14,358 shares in the company, valued at approximately $6,461,387.16. The trade was a 19.12% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.56% of the company's stock.

Synopsys Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source